Heart failure screening trial for diabetes patients
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial helps primary care providers screen and prevent heart failure in people with Type 2 diabetes. It uses a simple blood test to find early signs of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a primary care provider (like a doctor, nurse practitioner, or physician assistant).
- You see patients with Type 2 diabetes in your clinic.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special software (Ultromics EchoGo) that looks at your heart ultrasound to find people with type 2 diabetes who are at high risk for heart failure. If you're at risk, the software helps your doctor decide on treatments to prevent heart failure.
This trial is testing a simple screening tool to find early signs of heart failure in people aged 50 or older, especially those with risk factors like diabetes or high blood pressure. If you're at risk, this could help catch heart problems sooner.
This study tests a new way to find people who might develop heart failure early, using electronic health records. If you are at risk, screening could help start care sooner and prevent serious problems.
This trial tests whether simple screening using a blood test (natriuretic peptides) plus an ultrasound of the heart (echocardiogram) can find early heart failure sooner. Finding it earlier may help doctors start the right management to prevent it from getting worse.
This study looks at blood tests (called biomarkers) to see if they can help predict chronic heart failure risk. It focuses on adults with type 2 diabetes over age 50 who do not already have certain heart conditions.
This study is looking for people who may have undiagnosed heart failure. It tests a self-screening method at home to find heart problems earlier.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.